These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36268225)

  • 1. Overrepresentation of Enterobacteriaceae and
    Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
    Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host.
    Seishima J; Iida N; Kitamura K; Yutani M; Wang Z; Seki A; Yamashita T; Sakai Y; Honda M; Yamashita T; Kagaya T; Shirota Y; Fujinaga Y; Mizukoshi E; Kaneko S
    Genome Biol; 2019 Nov; 20(1):252. PubMed ID: 31767028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli Strains from Patients with Inflammatory Bowel Diseases have Disease-specific Genomic Adaptations.
    Dubinsky V; Reshef L; Rabinowitz K; Wasserberg N; Dotan I; Gophna U
    J Crohns Colitis; 2022 Nov; 16(10):1584-1597. PubMed ID: 35560165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes.
    Labbé A; Ganopolsky JG; Martoni CJ; Prakash S; Jones ML
    PLoS One; 2014; 9(12):e115175. PubMed ID: 25517115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siderophore Immunization Restricted Colonization of Adherent-Invasive Escherichia coli and Ameliorated Experimental Colitis.
    Gerner RR; Hossain S; Sargun A; Siada K; Norton GJ; Zheng T; Neumann W; Nuccio SP; Nolan EM; Raffatellu M
    mBio; 2022 Oct; 13(5):e0218422. PubMed ID: 36094114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.
    Tiwana H; Wilson C; Walmsley RS; Wakefield AJ; Smith MS; Cox NL; Hudson MJ; Ebringer A
    Rheumatol Int; 1997; 17(1):11-6. PubMed ID: 9194209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis.
    Lehmann T; Schallert K; Vilchez-Vargas R; Benndorf D; Püttker S; Sydor S; Schulz C; Bechmann L; Canbay A; Heidrich B; Reichl U; Link A; Heyer R
    J Proteomics; 2019 Jun; 201():93-103. PubMed ID: 31009805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
    Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
    Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
    Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
    Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.